ArticleAdvances in therapy2020
Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis.
Petri Mankinen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleAdvances in therapy2020
Petri Mankinen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.